Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Muscle Invasive Bladder Urothelial Carcinoma × avelumab × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Pancreatic Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Motor Activity 1 Melanoma 1 Lymphoma, B-Cell 1 Head and Neck Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1

Interventions

sacituzumab govitecan 1 pembrolizumab 1 erdafitinib 1 enfortumab vedotin 1 avelumab 1 Vinblastine 1 Paclitaxel 1 Nivolumab 1 Methotrexate 1 Gemcitabine 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06204614 2024-01-12

Drug Screening Using IMD in Bladder Cancer

Brigham and Women's Hospital

Phase EARLY_PHASE1 Unknown

Muscle Invasive Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡